Richard A. Meier - May 2, 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
May 2, 2022
Transactions value $
$65
Form type
4
Date filed
5/4/2022, 12:21 PM
Previous filing
Feb 4, 2022
Next filing
May 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Options Exercise $318K +8.5K +8.55% $37.46 108K May 2, 2022 Direct
transaction BMRN Common Stock Sale -$317K -3.86K -3.58% $82.09 104K May 2, 2022 Direct
transaction BMRN Common Stock Sale -$1.48K -18 -0.02% $82.12 104K May 2, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -8.5K -100% $0.00* 0 May 2, 2022 Common Stock 8.5K $37.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the number of options outstanding after the transactions from this specific stock option grant.